WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on AUGUST 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR August 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

EPIDEMIOLOGY OF MUSCULOSKELETAL MALIGNANCIES IN BASRAH

*Omar Noaman Omar Alashaq, Alaa Hisham Yaqoub, Noor Hasan Mohammed Taqi, Abbas ebjaree kawad

ABSTRACT

Background: Musculoskeletal malignancies, including primary and secondary bone and soft tissue cancers, are uncommon but represent an important public health concern because of their associated morbidity and mortality. Describing their epidemiological characteristics is essential for improving diagnosis, management, and cancer surveillance. Methods: This cross-sectional, record-based study reviewed all registered musculoskeletal malignancies in Basrah Governorate, Iraq, from 2005 to 2009. Demographic and clinicopathological data, including age, sex, residence, anatomical site, and histopathological diagnosis, were extracted and analysed. Annual incidence rates were estimated using population data. Results: A total of 357 musculoskeletal malignancies were identified, including 202 bone cancers and 137 soft tissue cancers. There were 210 males and 147 females (male-to-female ratio 1.43:1), with ages ranging from 6 months to 87 years. The second decade of life was the most frequently affected age group (18.2%). The mean annual incidence rate was 3.12 per 100,000 populations, comprising 1.77 per 100,000 for bone cancers and 1.20 per 100,000 for soft tissue cancers. Primary tumours accounted for 265 cases, secondary tumours for 74, and 18 cases were unspecified. The lower limbs and pelvis were the most commonly involved sites. Metastatic bone tumours (26.7%) and fibroblastic/myofibroblastic soft tissue tumours (24.8%) were the predominant histological types. Only 2.2% of cases originated from the eastern area of Basrah. Conclusions: Musculoskeletal malignancies in Basrah occurred more frequently than expected, predominantly affecting young individuals and males. Strengthening cancer registration systems and conducting further epidemiological studies are recommended to improve surveillance, early detection, and management of these rare malignancies.

[Full Text Article] [Download Certificate]